EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Targeting glycolysis in prostate cancer: Molecular mechanisms and therapeutic advances

Jiexiang Zhang, Tongtong Zhang, Dexin Song, Dongliang Xu

Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2026

DOI: 10.1016/j.bbcan.2026.189537 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2026. Verfasst von Jiexiang Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Urology Centre, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China; Surgical Institute of In…. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Glycolysis, Warburg Effect, Oncologic, Antineoplastic Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 268 Literaturangaben. Gefördert von: Shanghai University of Traditional Chinese Medicine, National Natural Science Foundation of China, Shanghai Shenkang Hospital Development Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Prostate cancer (PCa) is the second most common cancer among men worldwide and poses a significant threat to male health. A key feature of tumor progression is metabolic reprogramming, which involves the abnormal activation of glycolysis. This metabolic process supports PCa proliferation, metastasis, and drug resistance through rapid energy production, the provision of biosynthetic precursors, and the remodeling of the tumor microenvironment (TME). Key enzymes such as hexokinase 2 (HK2), phosphofructokinase (PFK), pyruvate kinase M2 (PKM2), glucose transporters (GLUTs), and lactate dehydrogenase A (LDHA) play pivotal roles in regulating aerobic glycolysis in PCa cells. Glycolytic enzymes are modulated by a variety of mechanisms, including the PI3K/AKT and AMPK signaling pathways, hypoxia-inducible factor 1α (HIF-1α), c-Myc, and non-coding RNAs. Current therapeutic strategies targeting glycolysis include natural products and small-molecule inhibitors. Targeting glycolysis presents novel opportunities to address existing limitations in PCa management. This review discusses the advances, challenges, and future research directions in glycolysis-focused PCa studies, providing a theoretical foundation for the development of precise metabolic interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsGlycolysisWarburg Effect, OncologicAntineoplastic AgentsHumansMaleSignal TransductionMetabolic ReprogrammingTumor MicroenvironmentAnimalsMolecular Targeted Therapy

Stichwörter der Autor:innen

GlycolysisMetabolic reprogrammingMolecular mechanismProstate cancerTherapeutic advanceWarburg effect

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Urology Centre, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China; Surgical Institute of Integrative Medicine, Shuguang Hospital Affiliated to Shanghai Universit…

Förderung

  • Shanghai University of Traditional Chinese Medicine
  • National Natural Science Foundation of China
  • Shanghai Shenkang Hospital Development Center

Zitieren

APA

Zhang, J., Zhang, T., Song, D., & Xu, D. (2026). Targeting glycolysis in prostate cancer: Molecular mechanisms and therapeutic advances. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. https://doi.org/10.1016/j.bbcan.2026.189537

Vancouver

Zhang J, Zhang T, Song D, Xu D. Targeting glycolysis in prostate cancer: Molecular mechanisms and therapeutic advances. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2026. doi:10.1016/j.bbcan.2026.189537

BibTeX
@article{Zhang2026,
  author = {Zhang, Jiexiang and Zhang, Tongtong and Song, Dexin and Xu, Dongliang},
  title = {Targeting glycolysis in prostate cancer: Molecular mechanisms and therapeutic advances},
  journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
  year = {2026},
  doi = {10.1016/j.bbcan.2026.189537}
}
Kostenlos starten →